|
|
||||||||


* Center for Infectious Diseases, and Departments of
Molecular Genetics and Microbiology and
Pathology, School of Medicine, Stony Brook University, Stony Brook, NY 11794
Naturally acquired infections with Francisella tularensis, the bacterial agent of tularemia, occur infrequently in humans. However, the high infectivity and lethality of the organism in humans raise concerns that it might be exploited as a weapon of bioterrorism. Despite this potential for illicit use, the pathogenesis of tularemia is not well understood. To examine how F. tularensis interacts with cells of its mammalian hosts, we tested the ability of a live vaccine strain (LVS) to induce proinflammatory changes in cultured HUVEC. Living F. tularensis LVS induced HUVEC to express the adhesion molecules VCAM-1 and ICAM-1, but not E-selectin, and to secrete the chemokine CXCL8, but not CCL2. Stimulation of HUVEC by the living bacteria was partially suppressed by polymyxin B, an inhibitor of LPS, but did not require serum, suggesting that F. tularensis LVS does not stimulate endothelium through the serum-dependent pathway that is typically used by LPS from enteric bacteria. In contrast to the living organisms, suspensions of killed F. tularensis LVS acquired the ability to increase endothelial expression of both E-selectin and CCL2. Up-regulation of E-selectin and CCL2 by the killed bacteria was not inhibited by polymyxin B. Exposure of HUVEC to either live or killed F. tularensis LVS for 24 h promoted the transendothelial migration of subsequently added neutrophils. These data indicate that multiple components of F. tularensis LVS induce proinflammatory changes in endothelial cells in an atypical manner that may contribute to the exceptional infectivity and virulence of this pathogen.
This article has been cited by other articles:
![]() |
A. A. Melillo, M. Mahawar, T. J. Sellati, M. Malik, D. W. Metzger, J. A. Melendez, and C. S. Bakshi Identification of Francisella tularensis Live Vaccine Strain CuZn Superoxide Dismutase as Critical for Resistance to Extracellularly Generated Reactive Oxygen Species J. Bacteriol., October 15, 2009; 191(20): 6447 - 6456. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Moreland, J. S. Hook, G. Bailey, T. Ulland, and W. M. Nauseef Francisella tularensis directly interacts with the endothelium and recruits neutrophils with a blunted inflammatory phenotype Am J Physiol Lung Cell Mol Physiol, June 1, 2009; 296(6): L1076 - L1084. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Savitt, P. Mena-Taboada, G. Monsalve, and J. L. Benach Francisella tularensis Infection-Derived Monoclonal Antibodies Provide Detection, Protection, and Therapy Clin. Vaccine Immunol., March 1, 2009; 16(3): 414 - 422. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Qin, D. W. Scott, J. A. Thompson, and B. J. Mann Identification of an Essential Francisella tularensis subsp. tularensis Virulence Factor Infect. Immun., January 1, 2009; 77(1): 152 - 161. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Shirey, L. E. Cole, A. D. Keegan, and S. N. Vogel Francisella tularensis Live Vaccine Strain Induces Macrophage Alternative Activation as a Survival Mechanism J. Immunol., September 15, 2008; 181(6): 4159 - 4167. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Chakraborty, M. Monfett, T. M. Maier, J. L. Benach, D. W. Frank, and D. G. Thanassi Type IV Pili in Francisella tularensis: Roles of pilF and pilT in Fiber Assembly, Host Cell Adherence, and Virulence Infect. Immun., July 1, 2008; 76(7): 2852 - 2861. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Qin, D. W. Scott, and B. J. Mann Francisella tularensis subsp. tularensis Schu S4 Disulfide Bond Formation Protein B, but Not an RND-Type Efflux Pump, Is Required for Virulence Infect. Immun., July 1, 2008; 76(7): 3086 - 3092. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gentry, J. Taormina, R. B. Pyles, L. Yeager, M. Kirtley, V. L. Popov, G. Klimpel, and T. Eaves-Pyles Role of Primary Human Alveolar Epithelial Cells in Host Defense against Francisella tularensis Infection Infect. Immun., August 1, 2007; 75(8): 3969 - 3978. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. E. Cole, K. A. Shirey, E. Barry, A. Santiago, P. Rallabhandi, K. L. Elkins, A. C. Puche, S. M. Michalek, and S. N. Vogel Toll-Like Receptor 2-Mediated Signaling Requirements for Francisella tularensis Live Vaccine Strain Infection of Murine Macrophages Infect. Immun., August 1, 2007; 75(8): 4127 - 4137. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Lindemann, M. K. McLendon, M. A. Apicella, and B. D. Jones An In Vitro Model System Used To Study Adherence and Invasion of Francisella tularensis Live Vaccine Strain in Nonphagocytic Cells Infect. Immun., June 1, 2007; 75(6): 3178 - 3182. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Wickstrum, K.-J. Hong, S. Bokhari, N. Reed, N. McWilliams, R. T. Horvat, and M. J. Parmely Coactivating Signals for the Hepatic Lymphocyte Gamma Interferon Response to Francisella tularensis Infect. Immun., March 1, 2007; 75(3): 1335 - 1342. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Malik, C. S. Bakshi, K. McCabe, S. V. Catlett, A. Shah, R. Singh, P. L. Jackson, A. Gaggar, D. W. Metzger, J. A. Melendez, et al. Matrix Metalloproteinase 9 Activity Enhances Host Susceptibility to Pulmonary Infection with Type A and B Strains of Francisella tularensis J. Immunol., January 15, 2007; 178(2): 1013 - 1020. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Rasmussen, J. Cello, H. Gil, C. A. Forestal, M. B. Furie, D. G. Thanassi, and J. L. Benach Mac-1+ Cells Are the Predominant Subset in the Early Hepatic Lesions of Mice Infected with Francisella tularensis Infect. Immun., December 1, 2006; 74(12): 6590 - 6598. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Morigi, S. Buelli, C. Zanchi, L. Longaretti, D. Macconi, A. Benigni, D. Moioli, G. Remuzzi, and C. Zoja Shigatoxin-Induced Endothelin-1 Expression in Cultured Podocytes Autocrinally Mediates Actin Remodeling Am. J. Pathol., December 1, 2006; 169(6): 1965 - 1975. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ben Nasr, J. Haithcoat, J. E. Masterson, J. S. Gunn, T. Eaves-Pyles, and G. R. Klimpel Critical role for serum opsonins and complement receptors CR3 (CD11b/CD18) and CR4 (CD11c/CD18) in phagocytosis of Francisella tularensis by human dendritic cells (DC): uptake of Francisella leads to activation of immature DC and intracellular survival of the bacteria J. Leukoc. Biol., October 1, 2006; 80(4): 774 - 786. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Gil, G. J. Platz, C. A. Forestal, M. Monfett, C. S. Bakshi, T. J. Sellati, M. B. Furie, J. L. Benach, and D. G. Thanassi Deletion of TolC orthologs in Francisella tularensis identifies roles in multidrug resistance and virulence PNAS, August 22, 2006; 103(34): 12897 - 12902. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. E. Cole, K. L. Elkins, S. M. Michalek, N. Qureshi, L. J. Eaton, P. Rallabhandi, N. Cuesta, and S. N. Vogel Immunologic Consequences of Francisella tularensis Live Vaccine Strain Infection: Role of the Innate Immune Response in Infection and Immunity. J. Immunol., June 1, 2006; 176(11): 6888 - 6899. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Katz, P. Zhang, M. Martin, S. N. Vogel, and S. M. Michalek Toll-Like Receptor 2 Is Required for Inflammatory Responses to Francisella tularensis LVS. Infect. Immun., May 1, 2006; 74(5): 2809 - 2816. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Gavrilin, I. J. Bouakl, N. L. Knatz, M. D. Duncan, M. W. Hall, J. S. Gunn, and M. D. Wewers Internalization and phagosome escape required for Francisella to induce human monocyte IL-1{beta} processing and release PNAS, January 3, 2006; 103(1): 141 - 146. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Bolger, C. A. Forestal, J. K. Italo, J. L. Benach, and M. B. Furie The live vaccine strain of Francisella tularensis replicates in human and murine macrophages but induces only the human cells to secrete proinflammatory cytokines J. Leukoc. Biol., June 1, 2005; 77(6): 893 - 897. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Gil, J. L. Benach, and D. G. Thanassi Presence of Pili on the Surface of Francisella tularensis Infect. Immun., May 1, 2004; 72(5): 3042 - 3047. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |